Osteoarthritis and COX-2 inhibitors
Lindberg, M.
Ugeskrift for Laeger 164(33): 3874
2002
ISSN/ISBN: 0041-5782 PMID: 12216162 Document Number: 541436
Document emailed within 1 workday
Related Documents
Andersen, S.E. 2002: Treatment of osteoarthritis with COX-2 inhibitors: good for the stomach, but bad for the patient? Ugeskrift for Laeger 164(33): 3874-3875Turajane, T.; Wongbunnak, R.; Patcharatrakul, T.; Ratansumawong, K.; Poigampetch, Y.; Songpatanasilp, T. 2009: Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis Journal of the Medical Association of Thailand 92(Suppl 6): S19-S26
Queneau, P.; Lejeune, E.; Veysseyre, C.; Titoulet, M.; Vallat, M.P.; Carraz, M. 1978: Our experience with the determination of serum anti-alphastaphylolysins and antigammastaphylolysins during infectious osteoarthritis. a personal series of 53 staphylococcal osteoarthritis cases, 14 cases of osteoarthritis from various germs, 47 extra-articular staphylococcal infections and 500 control subjects Revue du Rhumatisme et des Maladies Osteo-Articulaires 45(5): 325-333
Zak, M.Y.; Klymenko, M.O.; Iakovenko, N.O.; Grischenko, G.V. 2019: Medico-social value of osteoarthritis. secondary prevention and treatment of osteoarthritis in comorbidity with chronic gastritis Wiadomosci Lekarskie 72(5 Cz 2): 1064-1067
Avouac, B.; Maheu, E.; Sallière, D.; Charpak, Y.; Le Loet, X. 1990: Social impact of osteoarthritis. Risk/benefit--cost/effectiveness ratio of osteoarthritis treatments Revue du Rhumatisme et des Maladies Osteo-Articulaires 57(9): 37s-43s
Dougados, M. 2004: Outcome measures for clinical trials of disease modifying osteoarthritis drugs in patients with hip osteoarthritis Journal of Rheumatology. Suppl 70: 66-69
Ehrich, E.W.; Davies, G.M.; Watson, D.J.; Bolognese, J.A.; Seidenberg, B.C.; Bellamy, N. 2000: Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities osteoarthritis index questionnaire and global assessments in patients with osteoarthritis Journal of Rheumatology 27(11): 2635-2641
Barr, S.; Bellamy, N.; Buchanan, W.W.; Chalmers, A.; Ford, P.M.; Kean, W.F.; Kraag, G.R.; Gerecz-Simon, E.; Campbell, J. 1994: A comparative study of signal versus aggregate methods of outcome measurement based on the WOMAC Osteoarthritis Index. Western Ontario and McMaster Universities Osteoarthritis Index Journal of Rheumatology 21(11): 2106-2112
Hunter, D.J.; Zhang, Y.; Niu, J.; Tu, X.; Amin, S.; Goggins, J.; Lavalley, M.; Guermazi, A.; Gale, D.; Felson, D.T. 2005: Structural factors associated with malalignment in knee osteoarthritis: the Boston osteoarthritis knee study Journal of Rheumatology 32(11): 2192-2199
Verburg, A.F.E.; van den Donk, M.; Wiersma, T. 2019: Application of new glucose lowering drugs: DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors Nederlands Tijdschrift Voor Geneeskunde 163
Sumathi, S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part II-protease inhibitors of seeds Indian Journal of Biochemistry and Biophysics 13(1): 52-56
Green, L.J..; Yamauchi, P.S..; Kircik, L.H.. 2019: Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients with Psoriasis Journal of Drugs in Dermatology: Jdd 18(8): 776-788
Bhat, P.G.; Karnik, S.S.; Pattabiraman, T.N. 1976: Natural plant enzyme inhibitors: Part III-purification of protease inhibitors from Lathyrus sativus seeds Indian Journal of Biochemistry and Biophysics 13(4): 339-343
Rao, N.M.; Pattabiraman, T.N. 1985: Natural plant enzyme inhibitors: comparison of the action of tuber protease inhibitors on animal pancreatic systems Indian Journal of Biochemistry and Biophysics 22(6): 373-375
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Chang, G.; Ruggeri, R.B.; Harwood, H.James. 2002: Microsomal triglyceride transfer protein (MTP) inhibitors: discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms Current Opinion in Drug Discovery and Development 5(4): 562-570
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Posternak, M.A.; Zimmerman, M. 2005: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors: a retrospective study Journal of Clinical Psychiatry 66(6): 705-707
Shivaraj, B.; Sharma, K.K.; Pattabiraman, T.N. 1979: Natural plant enzyme inhibitors: Part VII--Alpha amylase inhibitors and amylases in plant tubers Indian Journal of Biochemistry and Biophysics 16(2): 52-55
Ohashi, K. 2002: MTP inhibitors and ACAT inhibitors. An update Nihon Rinsho. Japanese Journal of Clinical Medicine 60(5): 975-983